These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 8925599)
1. Accumulation of nuclear p53 protein and prognosis of astrocytomas in childhood and adolescence. Drach LM; Kammermeier M; Neirich U; Jacobi G; Kornhuber B; Lorenz R; Schlote W Clin Neuropathol; 1996; 15(2):67-73. PubMed ID: 8925599 [TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of TP53 mutations and P53 protein overexpression in supratentorial WHO grade II astrocytomas and oligoastrocytomas. Peraud A; Kreth FW; Wiestler OD; Kleihues P; Reulen HJ Clin Cancer Res; 2002 May; 8(5):1117-24. PubMed ID: 12006527 [TBL] [Abstract][Full Text] [Related]
3. p53 expression in Wilms' tumor: a possible role as prognostic factor. Beniers AJ; Efferth T; Füzesi L; Granzen B; Mertens R; Jakse G Int J Oncol; 2001 Jan; 18(1):133-9. PubMed ID: 11115550 [TBL] [Abstract][Full Text] [Related]
4. Role of gemistocytes in astrocytoma progression. Watanabe K; Tachibana O; Yonekawa Y; Kleihues P; Ohgaki H Lab Invest; 1997 Feb; 76(2):277-84. PubMed ID: 9042164 [TBL] [Abstract][Full Text] [Related]
5. Brainstem gliomas--a clinicopathological study of 45 cases with p53 immunohistochemistry. Badhe PB; Chauhan PP; Mehta NK Indian J Cancer; 2004; 41(4):170-4. PubMed ID: 15659871 [TBL] [Abstract][Full Text] [Related]
6. Possible association of p53 codon 72 polymorphism with susceptibility to adult and pediatric high-grade astrocytomas. Parhar P; Ezer R; Shao Y; Allen JC; Miller DC; Newcomb EW Brain Res Mol Brain Res; 2005 Jun; 137(1-2):98-103. PubMed ID: 15950766 [TBL] [Abstract][Full Text] [Related]
7. p53 protein alterations in adult astrocytic tumors and oligodendrogliomas. Nayak A; Ralte AM; Sharma MC; Singh VP; Mahapatra AK; Mehta VS; Sarkar C Neurol India; 2004 Jun; 52(2):228-32. PubMed ID: 15269478 [TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of TP53 mutation status for adult patients with supratentorial World Health Organization Grade II astrocytoma or oligoastrocytoma: a long-term analysis. Ständer M; Peraud A; Leroch B; Kreth FW Cancer; 2004 Sep; 101(5):1028-35. PubMed ID: 15329912 [TBL] [Abstract][Full Text] [Related]
9. The prognostic significance of p53 and bcl-2 expression in lung adenocarcinoma and its correlation with Ki-67 growth fraction. Ishida H; Irie K; Itoh T; Furukawa T; Tokunaga O Cancer; 1997 Sep; 80(6):1034-45. PubMed ID: 9305703 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of four antibodies in detecting p53 protein for predicting clinicopathological and prognostic significance in colorectal adenocarcinoma. Zhang Hong Clin Cancer Res; 1999 Dec; 5(12):4126-32. PubMed ID: 10632350 [TBL] [Abstract][Full Text] [Related]
11. p53 mutation and protein alteration in 50 gliomas. Retrospective study by DNA-sequencing techniques and immunohistochemistry. von Eckardstein K; Gries H; Bolik E; Cervós-Navarro J; Tschairkin IN; Patt S Histol Histopathol; 1997 Jul; 12(3):611-6. PubMed ID: 9225141 [TBL] [Abstract][Full Text] [Related]
12. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma. Leins A; Riva P; Lindstedt R; Davidoff MS; Mehraein P; Weis S Cancer; 2003 Dec; 98(11):2430-9. PubMed ID: 14635078 [TBL] [Abstract][Full Text] [Related]
13. Proliferative activity (MIB-1 index) is an independent prognostic parameter in patients with high-grade soft tissue sarcomas of subtypes other than malignant fibrous histiocytomas: a retrospective immunohistological study including 216 soft tissue sarcomas. Jensen V; Sørensen FB; Bentzen SM; Ladekarl M; Nielsen OS; Keller J; Jensen OM Histopathology; 1998 Jun; 32(6):536-46. PubMed ID: 9675593 [TBL] [Abstract][Full Text] [Related]
14. Spinal cord malignant astrocytomas. Clinicopathologic features in 36 cases. Santi M; Mena H; Wong K; Koeller K; Olsen C; Rushing EJ Cancer; 2003 Aug; 98(3):554-61. PubMed ID: 12879473 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival. Hiura T; Khalid H; Yamashita H; Tokunaga Y; Yasunaga A; Shibata S Cancer; 1998 Dec; 83(11):2361-9. PubMed ID: 9840536 [TBL] [Abstract][Full Text] [Related]
17. Fas (Apo-1, CD95) receptor expression in childhood astrocytomas. Is it a marker of the major apoptotic pathway or a signaling receptor for immune escape of neoplastic cells? Bodey B; Bodey B; Siegel SE; Kaiser HE In Vivo; 1999; 13(4):357-73. PubMed ID: 10586378 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical detection of p53 protein expression in various childhood astrocytoma subtypes: significance in tumor progression. Bodey B; Gröger AM; Bodey B; Siegel SE; Kaiser HE Anticancer Res; 1997; 17(2A):1187-94. PubMed ID: 9137469 [TBL] [Abstract][Full Text] [Related]
19. Prognostic value of p53 expression in Wilms' tumor in children. Skotnicka-Klonowicz G; Kobos J; Łoś E; Trejster E; Szymik-Kontorowicz S; Daszkiewicz P Med Sci Monit; 2001; 7(6):1224-9. PubMed ID: 11687734 [TBL] [Abstract][Full Text] [Related]
20. p53 overexpression is not an independent prognostic factor for patients with primary ovarian epithelial cancer. Eltabbakh GH; Belinson JL; Kennedy AW; Biscotti CV; Casey G; Tubbs RR; Blumenson LE Cancer; 1997 Sep; 80(5):892-8. PubMed ID: 9307189 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]